During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
News|Articles|May 14, 2009
2008 Top branded drugs by total retail dollars
2008 Top 100 branded drugs by total dollars spent
Advertisement
Advertisement
Related to this article
Foundational Pharmacy Strategies’ Christine Johnston on how rebate structures, pending legislation, and a stalled pipeline are reshaping — and threatening — the biosimilar market heading into 2027.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Long-acting lenacapavir plus cabotegravir kept all 46 patients with HIV virally suppressed in recent trial
2
Chad Hatfield, Pharm.D., on the 340B uncertainty facing health systems| HSES 2026
3
Why biosimilars keep losing ground to brand-name rivals: A Q&A with Christine Johnston, MBA
4
On the relentless rise in healthcare spending, price vs. utilization, and what employers should do about it | A conversation with Katie Martin, M.P.A.
5